Computerized surveillance of adverse drug reactions in hospital: Implementation

European Journal of Clinical Pharmacology

Volumn 54, Issue 11, 1999, Pages 887-892

  Levy, M ^a   Azaz Livshits, T ^a   Sadan, B ^a   Shalit, M ^a   Geisslinger, G ^b   Brune, K ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Adverse drug reactions; Hospital drug surveillance; Hospital information systems; Hospital pharmacoepidemiology

Indexed keywords

AMANTADINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIASTHMATIC AGENT; ANTICONVULSIVE AGENT; CAPTOPRIL; CARBAMAZEPINE; CARDIOVASCULAR AGENT; CORTICOSTEROID; CYCLOSPORIN; DIGOXIN; ENALAPRIL; ERYTHROMYCIN; FUROSEMIDE; HEPARIN; HYDRALAZINE; HYDROCORTISONE; IMIPRAMINE; IMMUNOSUPPRESSIVE AGENT; METFORMIN; METHADONE; NITRATE; PARACETAMOL; PREDNISONE; QUINIDINE; RANITIDINE; SIMVASTATIN; TACROLIMUS; THEOPHYLLINE; UNINDEXED DRUG;

ARTICLE; BONE MARROW TOXICITY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG MONITORING; HOSPITAL PHARMACY; HUMAN; LABORATORY DIAGNOSIS; LIVER TOXICITY; NEPHROTOXICITY; PHYSICIAN; PRIORITY JOURNAL;

ADVERSE DRUG REACTION REPORTING SYSTEMS; HOSPITAL INFORMATION SYSTEMS; HUMANS; LABORATORIES, HOSPITAL; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PATHOLOGY, CLINICAL; PROSPECTIVE STUDIES;

EID: 0032917472     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050571     Document Type: Article

References (29)

1. 1. Azaz-Livshits T, Levy M, Sadan B, et al (1998) Computerized surveillance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol 45: 309-314
2. 2. Naranjo S, Busto U, Sellers EM, et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239-245
3. 3. Levy M, Kletter-Hemo D, Nir I, Eliakim M (1977) Drug utilization and adverse drug reactions in medical patients: comparison of two periods, 1969 1972 and 1973 1976. Isr J Med Sci 13: 1065-1072
4. 4. Michel DJ, Knodel LC (1986) Program coordinated by a drug information service to improve adverse drug reaction in a hospital. Am J Hosp Pharm 43: 2202-2205
5. 5. Kennedy DL, Johnson JM, Nightingale SL (1991) Monitoring of adverse drug events in hospitals. JAMA 266: 2878
6. 6. Levy M, Kewitz H, Altwein W, Hillerbrand J, Eliakim M (1980) Hospital admissions due to adverse drug reactions: a comparative study from Jerusalem and Berlin. Eur J Clin Pharmacol 17: 25-31
7. 7. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalized patients: excess length of stay, extra costs and attributable mortality. JAMA 277: 301-306
8. 8. Bates DW, Spell NS, Cullen DJ, et al (1997) The costs of adverse drug events in hospitalized patients. JAMA 277: 307-317
9. 9. Leape LL, Brennan TA, Laird NM, et al (1991) The nature of adverse events in hospital patients: results of the Harvard Medical Practice Study H. N Engl J Med 324: 377-384
10. 10. Joint Commission on Accreditation of Healthcare Organizations. Accreditation manual for hospitals. 1992 ed. Chicago: Joint Commission for the Accreditation of Healthcare Organizations, 1992
11. 11. World Health Organization International Drug Monitoring (1969) The role of the hospital. WHO Tech Rep Ser 426: 5-24
12. 12. Smith CC, Bennett PM, Pearce HM, et al (1996) Adverse reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 42: 423-429
13. 13. Prosser TR, Kamysz PL (1990) Multidisciplinary adverse drug reaction surveillance program. Am J Hosp Pharm 47: 1334-1339
14. 14. Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP (1994) Preventing adverse drug events in hospitalized patients. Ann Pharmacother 28: 523-527
15. 15. O'Niel AC, Petersen LA, Cook F, Bates DW, Lee TH, Vrennan TA (1993) Physician reporting compared with medical record review to identify adverse medical events. Ann Intern Med 119: 370-376
16. 16. Bennett BS, Lipman AG (1977) Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. Am J Hosp Pharm 34: 931-936
17. 17. Berry LL, Segal R, Sherrin TP, Fudge KA (1988) Sensitivity and specificity of three methods of detecting adverse drug reactions. Am J Hosp Pharm 45: 1534-1539
18. 18. Schiff GD (1990) Using a computerized discharge summary data base check box for adverse drug reaction monitoring. Qual Rev Bull 16: 149-155
19. 19. Hulse RK, Clark SJ, Jackson JC, Warner HR, Gardner RM (1976) Computerized medication monitoring system. Am J Hosp Pharm 3: 1061-1064
20. 20. Evans RS, Pestotnik SL, Classen DC, et al (1991) Development of a computerized adverse drug event monitor. Proc Annu Symp Comput Appl Med Care 15: 23-27
21. 21. Leape LL, Bates DW, Cullen DJ, et al (1995) Systems analysis of adverse drug events. JAMA 4: 35-43
22. 22. Grasela CH, Walawander CA, Kennedy DL, Jolson HM (1993) Capability of hospital computer systems in performing drug-use evaluations and adverse drug event monitoring. Am J Hosp Pharm 50: 1889-1895
23. 23. Gronroos P, Irjala K, Heiskanen J, Troniainenk K, Forsstrom JJ (1995) Using computerized individual medication data to detect drug effects on clinical laboratory tests. Scand J Lab Invest 55 [Suppl 223]: 31-36
24. 24. Classen DC, Pestotnik SL, Evans RS, Burke JP (1991) Computerized surveillance of adverse drug events in hospital patients. JAMA 266: 2847-2851
25. 25. Classen DC, Burke JP (1995) The computer-based patient record: the role of the hospital epidemiologist. Infect Control Hosp Epidemiol 6: 729-736
26. 26. Bates DW, O'Neil AC, Boyl D, Teich J, Chertow GM, Komaroff AL, Brennan TW (1994) Potential identifiability and preventability of adverse events using hospital information systems. J Am Med Inform Assoc 5: 404-411
27. 27. Crawford SY, Myers CE (1993) ASHP national survey of hospital-based pharmaceutical services 1992. Am J Hosp Pharm 50 (7): 1371-1404
28. 28. Sivaram CA, Johnson S, Tirmizi SN, Robertson V, Garcia D, Sorrells E (1996) Morning report: a Forum for reporting adverse drug reactions. Jt Comm J Qual Improv 22: 259-263
29. 29. Pearson TF, Pittman DG, Longley JM, et al (1994) Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 51: 2268-2272